247 related articles for article (PubMed ID: 25832619)
1. Industry Collaboration and Primary Guest Authorship of High-Impact Randomized Clinical Trials: A Cross-Sectional Study.
Roper N; Korenstein D
J Gen Intern Med; 2015 Oct; 30(10):1421-5. PubMed ID: 25832619
[TBL] [Abstract][Full Text] [Related]
2. Collaboration and Authorship of High-Impact Randomized Clinical Trials.
Marchington J; Gertel A; Hamilton CW
J Gen Intern Med; 2016 Jan; 31(1):11. PubMed ID: 26001542
[No Abstract] [Full Text] [Related]
3. Industry Collaboration and Primary Guest Authorship of High-Impact Clinical Trials.
Roper N; Korenstein D
J Gen Intern Med; 2016 Jan; 31(1):12. PubMed ID: 26014893
[No Abstract] [Full Text] [Related]
4. Authorship criteria and disclosure of contributions: comparison of 3 general medical journals with different author contribution forms.
Bates T; Anić A; Marusić M; Marusić A
JAMA; 2004 Jul; 292(1):86-8. PubMed ID: 15238595
[TBL] [Abstract][Full Text] [Related]
5. Guest authorship and ghostwriting in publications related to rofecoxib: a case study of industry documents from rofecoxib litigation.
Ross JS; Hill KP; Egilman DS; Krumholz HM
JAMA; 2008 Apr; 299(15):1800-12. PubMed ID: 18413874
[TBL] [Abstract][Full Text] [Related]
6. On Ghosts and Other Unwelcome Guests.
Ross JS
J Gen Intern Med; 2015 Oct; 30(10):1389-91. PubMed ID: 25986141
[No Abstract] [Full Text] [Related]
7. Requirements and definitions in conflict of interest policies of medical journals.
Blum JA; Freeman K; Dart RC; Cooper RJ
JAMA; 2009 Nov; 302(20):2230-4. PubMed ID: 19934424
[TBL] [Abstract][Full Text] [Related]
8. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
[TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
10. Survey of conflict-of-interest disclosure policies of ophthalmology journals.
Anraku A; Jin YP; Trope GE; Buys YM
Ophthalmology; 2009 Jun; 116(6):1093-6. PubMed ID: 19376583
[TBL] [Abstract][Full Text] [Related]
11. Industry sponsorship and authorship of clinical trials over 20 years.
Buchkowsky SS; Jewesson PJ
Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
[TBL] [Abstract][Full Text] [Related]
12. Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials.
Bhandari M; Busse JW; Jackowski D; Montori VM; Schünemann H; Sprague S; Mears D; Schemitsch EH; Heels-Ansdell D; Devereaux PJ
CMAJ; 2004 Feb; 170(4):477-80. PubMed ID: 14970094
[TBL] [Abstract][Full Text] [Related]
13. Reporting of drug trial funding sources and author financial conflicts of interest in Cochrane and non-Cochrane meta-analyses: a cross-sectional study.
Turner K; Carboni-Jiménez A; Benea C; Elder K; Levis B; Boruff J; Roseman M; Bero L; Lexchin J; Turner EH; Benedetti A; Thombs BD
BMJ Open; 2020 May; 10(5):e035633. PubMed ID: 32398334
[TBL] [Abstract][Full Text] [Related]
14. The ICMJE Recommendations and pharmaceutical marketing--strengths, weaknesses and the unsolved problem of attribution in publication ethics.
Matheson A
BMC Med Ethics; 2016 Apr; 17():20. PubMed ID: 27044283
[TBL] [Abstract][Full Text] [Related]
15. Significance of authorship position: an open-ended international assessment.
Zbar A; Frank E
Am J Med Sci; 2011 Feb; 341(2):106-9. PubMed ID: 20924283
[TBL] [Abstract][Full Text] [Related]
16. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):471-8. PubMed ID: 22464101
[TBL] [Abstract][Full Text] [Related]
17. Editorial policy and the reporting of randomized controlled trials: a survey of instructions for authors and assessment of trial reports in Indian medical journals (2004-05).
Tharyan P; Premkumar TS; Mathew V; Barnabas JP; Manuelraj
Natl Med J India; 2008; 21(2):62-8. PubMed ID: 18807310
[TBL] [Abstract][Full Text] [Related]
18. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Rev Port Cardiol; 2012 Apr; 31(4):329-36. PubMed ID: 22863109
[TBL] [Abstract][Full Text] [Related]
19. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Eur Heart J; 2012 Mar; 33(5):587-94. PubMed ID: 22383145
[TBL] [Abstract][Full Text] [Related]
20. Conflict of interest policies and disclosure requirements among European Society of Cardiology National Cardiovascular Journals.
Alfonso F; Timmis A; Pinto FJ; Ambrosio G; Ector H; Kulakowski P; Vardas P;
Arq Bras Cardiol; 2012 Jun; 98(6):471-9. PubMed ID: 22892693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
